GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Asset Turnover

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Asset Turnover : 0.13 (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. GlaxoSmithKline Consumer Nigeria's Revenue for the three months ended in Jun. 2023 was ₦3,732 Mil. GlaxoSmithKline Consumer Nigeria's Total Assets for the quarter that ended in Jun. 2023 was ₦29,827 Mil. Therefore, GlaxoSmithKline Consumer Nigeria's Asset Turnover for the quarter that ended in Jun. 2023 was 0.13.

Asset Turnover is linked to ROE % through Du Pont Formula. GlaxoSmithKline Consumer Nigeria's annualized ROE % for the quarter that ended in Jun. 2023 was 7.88%. It is also linked to ROA % through Du Pont Formula. GlaxoSmithKline Consumer Nigeria's annualized ROA % for the quarter that ended in Jun. 2023 was 2.47%.


GlaxoSmithKline Consumer Nigeria Asset Turnover Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Asset Turnover Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 1.21 1.00 0.90 0.91

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.28 0.20 0.17 0.13

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Asset Turnover

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Asset Turnover distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Asset Turnover falls into.



GlaxoSmithKline Consumer Nigeria Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

GlaxoSmithKline Consumer Nigeria's Asset Turnover for the fiscal year that ended in Dec. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=25382.419/( (26252.732+29386.204)/ 2 )
=25382.419/27819.468
=0.91

GlaxoSmithKline Consumer Nigeria's Asset Turnover for the quarter that ended in Jun. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Jun. 2023 ))/ count )
=3731.801/( (29386.204+30268.016)/ 2 )
=3731.801/29827.11
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

GlaxoSmithKline Consumer Nigeria's annulized ROE % for the quarter that ended in Jun. 2023 is

ROE %**(Q: Jun. 2023 )
=Net Income/Total Stockholders Equity
=738.204/9373.447
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(738.204 / 14927.204)*(14927.204 / 29827.11)*(29827.11/ 9373.447)
=Net Margin %*Asset Turnover*Equity Multiplier
=4.95 %*0.5005*3.1821
=ROA %*Equity Multiplier
=2.47 %*3.1821
=7.88 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

GlaxoSmithKline Consumer Nigeria's annulized ROA % for the quarter that ended in Jun. 2023 is

ROA %(Q: Jun. 2023 )
=Net Income/Total Assets
=738.204/29827.11
=(Net Income / Revenue)*(Revenue / Total Assets)
=(738.204 / 14927.204)*(14927.204 / 29827.11)
=Net Margin %*Asset Turnover
=4.95 %*0.5005
=2.47 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) net income data. The Revenue data used here is four times the quarterly (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


GlaxoSmithKline Consumer Nigeria Asset Turnover Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines